Screening for gonorrhoea using samples collected through the English National Chlamydia Screening Programme and risk of false positives: A national survey of Local Authorities

BMJ Open

Volumn 4, Issue 10, 2014, Pages

  Field, Nigel ^a,b   Kennedy, Iain ^b   Folkard, Kate ^b   Duffell, Stephen ^b   Town, Katy ^b   Ison, Catherine A ^b   Hughes, Gwenda ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHLAMYDIA TRACHOMATIS; FALSE POSITIVE RESULT; GONORRHEA; HUMAN; MAJOR CLINICAL STUDY; MASS SCREENING; NEISSERIA GONORRHOEAE; NONHUMAN; PREDICTIVE VALUE; SCREENING TEST; SENSITIVITY AND SPECIFICITY; UNITED KINGDOM; CHLAMYDIA INFECTIONS; FEMALE; INFORMATION PROCESSING; LABORATORY DIAGNOSIS; MALE; NUCLEIC ACID AMPLIFICATION; PREVALENCE; YOUNG ADULT;

ADOLESCENT; CHLAMYDIA INFECTIONS; DATA COLLECTION; ENGLAND; FALSE POSITIVE REACTIONS; FEMALE; GONORRHEA; HUMANS; MALE; MASS SCREENING; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PREVALENCE; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; YOUNG ADULT;

EID: 84908138703     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2014-006067     Document Type: Article

References (31)

1. National chlamydia screening programme - NCSP home. http://www.chlamydiascreening.nhs.uk/ (accessed 25 Feb 2011).
2. HPA - CTAD: Chlamydia Testing Activity Dataset. http://www.hpa.org.uk/sexualhealth/ctad (accessed 30 May 2014).
3. Health and Social Care Act 2012, c.7. http://www.legislation.gov.uk/ukpga/2012/7/contents/enacted (accessed 30 May 2014).
4. British Association for Sexual Health and HIV. Chlamydia trachomatis UK Testing Guidelines. 2010. http://www.bashh.org/documents/3352.pdf (accessed 21 Feb 2014).
5. Bignell CJ. Commentary. Sex Transm Infect 2007;83:179-80. doi:10.1136/sti.2006.021816
6. Lavelle SJ, Jones KE, Mallinson H, et al. Finding, confirming, and managing gonorrhoea in a population screened for chlamydia using the Gen-Probe Aptima Combo2 assay. Sex Transm Infect 2006;82:221-4.
7. Lavelle SJ, Mallinson H, Henning SJ, et al. Impact on gonorrhoea case reports through concomitant/dual testing in a chlamydia screening population in Liverpool. Sex Transm Infect 2007;83:593-4.
8. Guidance for the detection of gonorrhoea in England; including guidance on the use of dual testing for chlamydia and gonorrhoea. Public Health England © Crown copyright (2014).
9. Fifer H, Ison CA. Nucleic acid amplification tests for the diagnosis of Neisseria gonorrhoeae in low-prevalence settings: a review of the evidence. Sex Transm Infect 2014:pii: sextrans-2014-051588.
10. Ison C. GC NAATs: is the time right? Sex Transm Infect 2006;82:515.
11. Sonnenberg P, Clifton S, Beddows S, et al. Prevalence, risk factors, and uptake of interventions for sexually transmitted infections in Britain: findings from the National Surveys of Sexual Attitudes and Lifestyles (Natsal). Lancet 2013;382:1795-806.
12. Public Health England. Health Protection Report. 2013. http://www.hpa.org.uk/hpr/archives/2013/hpr2313.pdf (accessed 6 Feb 2014).
13. Skidmore S, Copley S, Cordwell D, et al. Positive nucleic acid amplification tests for Neisseria gonorrhoeae in young people tested as part of the National Chlamydia Screening Programme. Int J STD AIDS 2011;22:398-9.
14. Fowler T, Edeghere O, Inglis N, et al. Estimating the positive predictive value of opportunistic population testing for gonorrhoea as part of the English Chlamydia Screening Programme. Int J STD AIDS 2013;24:185-91.
15. Downing J, Cook PA, Madden HCE, et al. Management of cases testing positive for gonococcal infection in a community-based chlamydia screening programme. Sex Transm Infect 2010;86:474-7.
16. Rao GG, Bacon L, Evans J, et al. Prevalence of Neisseria gonorrhoeae infection in young subjects attending community clinics in South London. Sex Transm Infect 2008;84:117-21.
17. Benzie A, Alexander S, Gill N, et al. Gonococcal NAATs: what is the current state of play in England and Wales? Int J STD AIDS 2010;21:246-8.
18. Dayan Y, Paine CS, Johnson AJ. Responding to sensitive questions in surveys: A comparison of results from Online panels, face to face and self-completion interviews. 2009. http://www.ipsos-mori.com/Assets/Docs/Publications/Ops-RMC-Responding-Sensitive-Questions-08-03-10.pdf (accessed 21 Feb 2014).
19. Public Health England. Genitourinary Medicine Clinic Activity Dataset (GUMCADv2). http://www.hpa.org.uk/gumcad (accessed 30 May 2014).
20. Gen-Probe products. Aptima Combo 2 product information webpage. http://www.gen-probe.com/products-services/aptima-combo (accessed 30 May 2014).
21. Hughes G, Evans BG, Ncube F, et al. PHE HIV and STI Data Sharing Policy version 4. 2014. http://www.hpa.org.uk/webc/HPAwebFile/HPAweb-C/1247816526850 (accessed 27 Jun 2014).
22. Payne RA, Abel GA. UK indices of multiple deprivation - a way to make comparisons across constituent countries easier. Health Stat Q 2012;53:22-37.
23. National Chlamydia Screening Programme, Health Protection Agency. National Chlamydia Screening Programme Standards. 6th edn. 2012. http://www.chlamydiascreening.nhs.uk/ps/resources/core-requirements/NCSP%20Standards%206th%20Edition-October%202012.pdf
24. Low N, Unemo M, Skov Jensen J, et al. Molecular diagnostics for gonorrhoea: implications for antimicrobial resistance and the threat of untreatable gonorrhoea. PLoS Med 2014;11:e1001598.
25. Katz AR, Effler PV, Ohye RG, et al. False-positive gonorrhea test results with a nucleic acid amplification test: the impact of low prevalence on positive predictive value. Clin Infect Dis 2004;38:814-19.
26. Guidance for the detection of gonorrhoea in England - Publications - GOV.UK. https://www.gov.uk/government/publications/guidance-for-the-detection-of-gonorrhoea-in-england (accessed 27 Aug 2014).
27. Klausner JD. The NAAT Is Out of the Bag. Clin Infect Dis 2004;38:820-1.
28. Andermann A, Blancquaert I, Beauchamp S, et al. Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years. Bull World Health Organ 2008;86. http://www.who.int/bulletin/volumes/86/4/07-050112/en/
29. Tucker JD, Bien CH, Peeling RW. Point-of-care testing for sexually transmitted infections: recent advances and implications for disease control. Curr Opin Infect Dis 2013;26:73-9.
30. Kriesel J, Bhatia A, Vaughn M, et al. P3-S5.05 Rapid point of care testing for ten sexually transmitted diseases. Sex Transm Infect 2011;87:A294-5.
31. Russek-Cohen E, Feldblyum T, Whitaker KB, et al. FDA perspectives on diagnostic device clinical studies for respiratory infections. Clin Infect Dis 2011;52:S305-11.